2009
DOI: 10.1007/s10753-009-9127-1
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Lipopeptide MALP-2 Inhibits Intracellular Growth of Mycobacterium bovis BCG in Alveolar Macrophages—Preliminary Data

Abstract: Alveolar macrophages (AM) are the primary target cell of the lung for inhaled mycobacterial pathogens. We investigated the effect of the synthetic lipopeptide MALP-2 on the interaction between AM from rats and Mycobacterium bovis BCG. AM were infected with M. bovis BCG at a multiplicity of infection (MOI) of 10 and then cultured in medium alone or medium supplemented with either synthetic macrophage activating lipopeptide-2 (MALP-2), or IFN-gamma, or both. Mycobacterial CFU were counted on days 3 and 7 and cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Also, results from Zeckey et al from a murine sepsis model might support a protective role of MALP-2 for lung tissue. While the significantly reduced levels of IL-6, TNF-α, and MIP-1α in the alveolar tissue found at the end of the observation period (96 h) might be interpreted as a residual pulmonary response on the one hand [10], Jörgens et al showed that local IL-10 in the lung was significantly increased after pre-treatment of alveolar macrophages with MALP-2 [21] on the other hand. Thus, local pre-treatment with MALP-2 might beneficially influence the lung against inflammation by elevated antiinflammatory IL-10 concentrations and lowered proinflammatory mediator levels.…”
Section: Immune Function and Organ Damage Of The Lungmentioning
confidence: 99%
“…Also, results from Zeckey et al from a murine sepsis model might support a protective role of MALP-2 for lung tissue. While the significantly reduced levels of IL-6, TNF-α, and MIP-1α in the alveolar tissue found at the end of the observation period (96 h) might be interpreted as a residual pulmonary response on the one hand [10], Jörgens et al showed that local IL-10 in the lung was significantly increased after pre-treatment of alveolar macrophages with MALP-2 [21] on the other hand. Thus, local pre-treatment with MALP-2 might beneficially influence the lung against inflammation by elevated antiinflammatory IL-10 concentrations and lowered proinflammatory mediator levels.…”
Section: Immune Function and Organ Damage Of The Lungmentioning
confidence: 99%